Evidence map›Paper›PMID 40893891›Full record

ArticleFrontiers in medicine2025

Case Report: Membranous nephropathy associated with mantle cell lymphoma: a rare case.

Mian Ren, Luxi Cao, Quanquan Shen, Bin Zhu, Juan Wu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mian RenDepartment of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Urology and Nephrology Center, Hangzhou Medical College, Hangzhou, China.
Luxi CaoDepartment of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Urology and Nephrology Center, Hangzhou Medical College, Hangzhou, China.
Quanquan ShenDepartment of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Urology and Nephrology Center, Hangzhou Medical College, Hangzhou, China.
Bin ZhuDepartment of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Urology and Nephrology Center, Hangzhou Medical College, Hangzhou, China.
Juan WuDepartment of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Urology and Nephrology Center, Hangzhou Medical College, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mantle cell lymphoma (MCL) is a rare, aggressive non-Hodgkin lymphoma (NHL) that can affect the kidneys. In this research, we described a very rare case of secondary membranous nephropathy (MN) associated with MCL. A 67-year-old man manifested with impaired renal function and nephrotic syndrome (NS). Kidney biopsy revealed atypical MN and MCL cell infiltration. After eight rounds of modified R-CHOP therapy, which includes rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone, the patient achieved complete remission, accompanied by improved renal function and a reduction in proteinuria. This case demonstrates the precise diagnosis and treatment of the primary disease, which can lead to favorable outcomes.

Indexed as

mantle cell lymphomamembranous nephropathynephrotic syndromenon-Hodgkin lymphomasecondary nephropathy

Identifiers

PMID40893891
PMCPMC12394139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.